One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.

But what if you had the insights to effectively evaluate a company like National Research Corporation before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell National Research Corporation’s stock is to have the right tools and resources as well as a clear monitoring process.

In this article, we go over a few key elements for understanding National Research Corporation’s stock price such as:

• Current stock price and volume
• Stock price history
• Upgrades and downgrades from analysts
• Stock price momentum as measured by its relative strength

About National Research Corporation (NRC)

Before we jump into National Research Corporation’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

National Research Corporation is a provider of analytics and insights for healthcare organizations in the United States and Canada. The Company's portfolio of solutions include Market Insights solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators; and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools; Experience solutions are provided on a subscription basis namely a cross-continuum multi-mode digital platform that collects and measures data and then delivers business intelligence that our clients utilize to improve patient experience, engagement and loyalty; and Transparency solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.

Want to learn more about National Research Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about National Research Corporation. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.

National Research Corporation’s Stock Price as of Market Close

As of March 30, 2023, 4:00 PM CST, National Research Corporation’s stock price was $42.66.

National Research Corporation is down 4.67% from its previous closing price of $44.75.

During the last market session, National Research Corporation’s stock traded between $44.14 and $45.22. Currently, there are 24.65 million shares of National Research Corporation stock available for purchase.

National Research Corporation’s price-earnings (P/E) ratio is currently at 35.3, which is high compared to the Business Support Services industry median of 21.9. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

National Research Corporation Stock Price History

National Research Corporation’s (NRC) price is currently down 5.54% so far this month.

During the month of March, National Research Corporation’s stock price has reached a high of $45.86 and a low of $41.61.

Over the last year, National Research Corporation has hit prices as high as $47.60 and as low as $30.93. Year to date, National Research Corporation’s stock is up 2.75%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused National Research Corporation Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 29, 2023, there were analysts who downgraded National Research Corporation’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate National Research Corporation’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

National Research Corporation’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about National Research Corporation (NRC) by visiting AAII Stock Evaluator.

Relative Price Strength of National Research Corporation

Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.

As of March 29, 2023, National Research Corporation has a weighted four-quarter relative price strength of 8.06%, which translates to a Momentum Score of 85 and is considered to be Very Strong.

Want to learn more about how National Research Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

National Research Corporation Stock Price: Bottom Line

As of March 30, 2023, National Research Corporation’s stock price is $42.66, which is down 4.67% from its previous closing price.

At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell National Research Corporation’s stock based on its stock price forecast is ultimately up to you.

It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.

By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.